FURLAN DANIELA

DANIELA FURLAN

ACADEMIC APPOINTMENTS
-Director, Residency Program in Clinical Pathology and Clinical Biochemistry, Univ. Insubria (2025–Present).
-Associate Professor (Laboratory Medicine, SSD MEDS-26/A), Univ. Insubria (2019–Present).
-Assistant Professor/Researcher (Anatomic Pathology, SSD MED08), Univ. Insubria (2001–2018).
-Technical Assistant, Univ. Pavia/Insubria (1993–2000): established the Molecular Biology Lab.
-Teaching: Chair of Laboratory Medicine Diagnostic Techniques; Faculty Member, PhD in Experimental Medicine.

CLINICAL APPOINTMENTS
-NGS Facility Coordinator (Lombardy Region), ASST Sette Laghi (2025–Present).
-Head of Molecular Pathology Unit, ASST Sette Laghi (2023–Present).
-Staff Scientist/Medical Director, ASST Sette Laghi (2002–Present).
-Quality Assurance: Lead for National (AIOM, SIAPEC) and European (EMQN) EQA programs since 2010.

EDUCATION
-Post-grad Specialization, Applied Genetics, Univ. Pavia (2000), 50/50 Summa Cum Laude.
-Research Fellow, National Cancer Institute (INT) Milan (1992–93): antibody humanization.
-M.Sc. Biological Sciences, Univ. Pavia (1990), 110/110 Summa Cum Laude.

RESEARCH PROFILE
-Focus on translational molecular pathology for biomarker validation (targeted and immunotherapy).
-Epigenetic instability: LINE-1 retrotransposons and DNA hyper/hypomethylation in intestinal and head & neck carcinogenesis.
-Multi-omic approach: integration of tissue data and bioinformatics for early molecular signatures.
-Precision Oncology: NGS for variants (SNV, in/del, fusions) and tumor inflammatory profiling.

METRICS & QUALIFICATIONS
-98 international publications; H-index: 34; Citations: 3401 (Scopus 09/02/25).
-ASN: Fully qualified for National Commission (MEDS-26/A).
-Core Technologies: NGS, Nanostring, Pyrosequencing, MLPA, Liquid Biopsy.